Home › AXLA
Biotechnology
AXLA
0.6752
  Price6.09%   -0.0438
(After Hours: .67 -0.0052 -0.77% )
loading

KEY STATS

Previous Close:
$0.719
Market Cap:
$49.66M
24h Volume:
233.71K
1D Range:
$0.6339 - $0.725
52W Range:
$0.1621 - $2.89
Primary Exchange:

COMPANY PROFILE

NameNameAxcella Health Inc
sectorSectorHealthcare (1373)
industryIndustryBiotechnology (814)
webWebaxcellahealth.com
phonePhone857-320-2200
employeeEmployee52
chart-line-icon Latest SEC Filings
twitter-icon AXLA's Discussions on Twitter
location840 Memorial Drive, Cambridge, MA, United States (2139)

AXLA’s Recommendation Trends & Predictions

Buy
0%
Hold
0%
Sell
0%

UPGRADES & DOWNGRADES

Initiated Noble Capital Markets: Outperform Oct-12-21
Downgrade Goldman: Buy → Neutral Sep-22-21
Downgrade JP Morgan: Neutral → Underweight Jul-30-21
Initiated H.C. Wainwright: Buy Jul-06-21
Resumed Chardan Capital Markets: Buy Jun-03-21
Initiated ROTH Capital: Buy Nov-18-20
Initiated Chardan Capital Markets: Buy Oct-27-20
Initiated B. Riley FBR: Buy Sep-25-20
Initiated Piper Sandler: Overweight Jul-31-20
Initiated Wedbush: Outperform May-28-20
Initiated BTIG Research: Buy May-01-20
Initiated Goldman: Buy Jun-03-19
Initiated JP Morgan: Overweight Jun-03-19
Initiated SVB Leerink: Outperform Jun-03-19
More Upgrades & Downgrades
News Options Chain Financials Insider Trading Discussions Forecast

Axcella Health Inc (AXLA) Options Chain

Calls Options of AXLA for 2023-02-17 (Expired in 9 days)

Strike Price Change % Change Volume
favorite 2.50 0.05 0.00 0.00% 0
favorite 5.00 0.18 0.00 0.00% 0
favorite 7.50 0.00 0.00 0.00% 0

Puts Options of AXLA for (Expired in 9 days)

Strike Price Change % Change Volume
favorite
2.50
 0.00 0.00 0.00% 0
favorite
5.00
 0.00 0.00 0.00% 0
favorite
7.50
 6.60 0.00 0.00% 0

About Axcella Health Inc

Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. The company develops its products based on its AXA Development Platform. It offers AXA1665 for use in treating hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was founded in 2008 and is based in Cambridge, Massachusetts.
Real-Time Dow Stock List Congresswoman Nancy Pelosi Stock Tracker Top 100 popular stocks on Robinhood
Open in Yahoo | Open in Google | Open in Finviz
Cap:    |  Volume (24h):